Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.

Wolf M, Koch TA, Bregman DB.

J Bone Miner Res. 2013 Aug;28(8):1793-803. doi: 10.1002/jbmr.1923.

2.

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.

Lyseng-Williamson KA, Keating GM.

Drugs. 2009;69(6):739-56. doi: 10.2165/00003495-200969060-00007. Review.

PMID:
19405553
3.
5.

[Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis].

Nabeshima Y.

Clin Calcium. 2008 Jul;18(7):923-34. doi: CliCa0807923934. Review. Japanese.

PMID:
18591743
6.
7.

Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.

Bergwitz C, Jüppner H.

Annu Rev Med. 2010;61:91-104. doi: 10.1146/annurev.med.051308.111339. Review.

8.

Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.

Wolf M, White KE.

Curr Opin Nephrol Hypertens. 2014 Jul;23(4):411-9. doi: 10.1097/01.mnh.0000447020.74593.6f. Review.

9.

[Phosphate metabolism and iron deficiency].

Yokoyama K.

Clin Calcium. 2016 Feb;26(2):241-9. doi: CliCa1602241249. Review. Japanese.

PMID:
26813504
10.

Klotho gene, phosphocalcic metabolism, and survival in dialysis.

Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G.

J Ren Nutr. 2009 Jan;19(1):50-6. doi: 10.1053/j.jrn.2008.10.018. Review.

PMID:
19121771
11.

[Bone and Nutrition. The relationship between iron and phosphate metabolism].

Takashi Y, Fukumoto S.

Clin Calcium. 2015 Jul;25(7):1037-42. doi: CliCa150710371042. Review. Japanese.

PMID:
26119317
12.

Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.

Toblli JE, Angerosa M.

Drug Des Devel Ther. 2014 Dec 11;8:2475-91. doi: 10.2147/DDDT.S55499. eCollection 2014. Review.

13.

Ferric carboxymaltose: a review of its use in iron deficiency.

Keating GM.

Drugs. 2015 Jan;75(1):101-27. doi: 10.1007/s40265-014-0332-3. Review.

PMID:
25428711
14.

[FGF23, a "new" hormone regulating phosphate homeostasis and vitamin D metabolism].

Silve C.

Presse Med. 2005 Nov 5;34(19 Pt 1):1384-90. Review. French.

PMID:
16292192
15.

[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].

Potthoff SA, Münch HG.

Dtsch Med Wochenschr. 2013 Jun;138(24):1312-7. doi: 10.1055/s-0033-1343219. Epub 2013 Jun 4. Review. German.

PMID:
23737117
16.

Forging forward with 10 burning questions on FGF23 in kidney disease.

Wolf M.

J Am Soc Nephrol. 2010 Sep;21(9):1427-35. doi: 10.1681/ASN.2009121293. Epub 2010 May 27. Review.

17.

[Regulatory mechanism of circulating inorganic phosphate].

Michigami T.

Clin Calcium. 2016 Feb;26(2):193-8. doi: CliCa1602193198. Review. Japanese.

PMID:
26813498
18.

Phosphate homeostasis and disorders.

Manghat P, Sodi R, Swaminathan R.

Ann Clin Biochem. 2014 Nov;51(Pt 6):631-56. doi: 10.1177/0004563214521399. Epub 2014 Feb 28. Review.

PMID:
24585932
19.

Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.

Seeherunvong W, Wolf M.

Pediatr Transplant. 2011 Feb;15(1):37-46. doi: 10.1111/j.1399-3046.2010.01405.x. Epub 2010 Oct 8. Review.

20.

Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia.

Bregman DB, Goodnough LT.

Ther Adv Hematol. 2014 Apr;5(2):48-60. doi: 10.1177/2040620714521127. Review.

Supplemental Content

Support Center